Ola Lindén

EANM Dosimetry Committee guidelines for bone marrow and whole-body dosimetry

Cécilia Hindorf, Gerhard Glatting, Ola Lindén et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2010 · 295 citations

Medicine, Nuclear Medicine, Radiation Oncology +16

Dose-Fractionated Radioimmunotherapy in Non-Hodgkin's Lymphoma Using DOTA-Conjugated, 90Y-Radiolabeled, Humanized Anti-CD22 Monoclonal Antibody, Epratuzumab

Ola Lindén, Cécilia Hindorf, Eva Cavallin‐Ståhl et al. · Clinical Cancer Research · 2005 · 116 citations · Full text

Medicine, Oncology, Pharmacology +16

⁹⁰Yttrium-Ibritumomab-Tiuxetan as First-Line Treatment for Follicular Lymphoma: 30 Months of Follow-Up Data From an International Multicenter Phase II Clinical Trial

Christian W. Scholz, Werner Linkesch, Ola Lindén et al. · Journal of Clinical Oncology · 2012 · 108 citations · Full text

Medicine, Hematology, Oncology +16

Regression of cervical spinal cord compression in a patient with chordoma following treatment with cetuximab and gefitinib

Ola Lindén, Lars Stenberg, Elisabeth Kjellén · Acta Oncologica · 2008 · 67 citations · Full text

Medicine, Oncology, Surgery +10

Long-term molecular remissions in patients with indolent lymphoma treated with rituximab as a single agent or in combination with interferon alpha-2a: A randomized phase II study from the Nordic Lymphoma Group

Eva Kimby, Jesper Jurlander, Christian H. Geisler et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2008 · 62 citations

Medicine, Immunology, Pharmacotherapy +15